Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing ce...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2009
|
| _version_ | 1826267350141239296 |
|---|---|
| author | van de Loosdrecht, A Alhan, C Béné, M Della Porta, MG Dräger, A Feuillard, J Font, P Germing, U Haase, D Homburg, C Ireland, R Jansen, J Kern, W Malcovati, L Te Marvelde, J Mufti, G Ogata, K Orfao, A Ossenkoppele, G Porwit, A Preijers, F Richards, S Schuurhuis, G Subirá, D Valent, P |
| author_facet | van de Loosdrecht, A Alhan, C Béné, M Della Porta, MG Dräger, A Feuillard, J Font, P Germing, U Haase, D Homburg, C Ireland, R Jansen, J Kern, W Malcovati, L Te Marvelde, J Mufti, G Ogata, K Orfao, A Ossenkoppele, G Porwit, A Preijers, F Richards, S Schuurhuis, G Subirá, D Valent, P |
| author_sort | van de Loosdrecht, A |
| collection | OXFORD |
| description | The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing cells in dysplastic bone marrow point to a useful role for multiparameter flow cytometry (FCM) in the diagnosis and prognostication of myelodysplastic syndromes. In March 2008, representatives from 18 European institutes participated in a European LeukemiaNet (ELN) workshop held in Amsterdam as a first step towards standardization of FCM in myelodysplastic syndromes. Consensus was reached regarding standard methods for cell sampling, handling and processing. The group also defined minimal combinations of antibodies to analyze aberrant immunophenotypes and thus dysplasia. Examples are altered numbers of CD34(+) precursors, aberrant expression of markers on myeloblasts, maturing myeloid cells, monocytes or erythroid precursors and the expression of lineage infidelity markers. When applied in practice, aberrant FCM patterns correlate well with morphology, the subclassification of myelodysplastic syndromes, and prognostic scoring systems. However, the group also concluded that despite strong evidence for an impact of FCM in myelodysplastic syndromes, further (prospective) validation of markers and immunophenotypic patterns are required against control patient groups as well as further standardization in multi-center studies. Standardization of FCM in myelodysplastic syndromes may thus contribute to improved diagnosis and prognostication of myelodysplastic syndromes in the future. |
| first_indexed | 2024-03-06T20:52:50Z |
| format | Journal article |
| id | oxford-uuid:382e18e4-4d52-4de8-866b-9c732ba94f8d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:52:50Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:382e18e4-4d52-4de8-866b-9c732ba94f8d2022-03-26T13:48:33ZStandardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:382e18e4-4d52-4de8-866b-9c732ba94f8dEnglishSymplectic Elements at Oxford2009van de Loosdrecht, AAlhan, CBéné, MDella Porta, MGDräger, AFeuillard, JFont, PGerming, UHaase, DHomburg, CIreland, RJansen, JKern, WMalcovati, LTe Marvelde, JMufti, GOgata, KOrfao, AOssenkoppele, GPorwit, APreijers, FRichards, SSchuurhuis, GSubirá, DValent, PThe myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing cells in dysplastic bone marrow point to a useful role for multiparameter flow cytometry (FCM) in the diagnosis and prognostication of myelodysplastic syndromes. In March 2008, representatives from 18 European institutes participated in a European LeukemiaNet (ELN) workshop held in Amsterdam as a first step towards standardization of FCM in myelodysplastic syndromes. Consensus was reached regarding standard methods for cell sampling, handling and processing. The group also defined minimal combinations of antibodies to analyze aberrant immunophenotypes and thus dysplasia. Examples are altered numbers of CD34(+) precursors, aberrant expression of markers on myeloblasts, maturing myeloid cells, monocytes or erythroid precursors and the expression of lineage infidelity markers. When applied in practice, aberrant FCM patterns correlate well with morphology, the subclassification of myelodysplastic syndromes, and prognostic scoring systems. However, the group also concluded that despite strong evidence for an impact of FCM in myelodysplastic syndromes, further (prospective) validation of markers and immunophenotypic patterns are required against control patient groups as well as further standardization in multi-center studies. Standardization of FCM in myelodysplastic syndromes may thus contribute to improved diagnosis and prognostication of myelodysplastic syndromes in the future. |
| spellingShingle | van de Loosdrecht, A Alhan, C Béné, M Della Porta, MG Dräger, A Feuillard, J Font, P Germing, U Haase, D Homburg, C Ireland, R Jansen, J Kern, W Malcovati, L Te Marvelde, J Mufti, G Ogata, K Orfao, A Ossenkoppele, G Porwit, A Preijers, F Richards, S Schuurhuis, G Subirá, D Valent, P Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title | Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title_full | Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title_fullStr | Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title_full_unstemmed | Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title_short | Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. |
| title_sort | standardization of flow cytometry in myelodysplastic syndromes report from the first european leukemianet working conference on flow cytometry in myelodysplastic syndromes |
| work_keys_str_mv | AT vandeloosdrechta standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT alhanc standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT benem standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT dellaportamg standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT dragera standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT feuillardj standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT fontp standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT germingu standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT haased standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT homburgc standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT irelandr standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT jansenj standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT kernw standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT malcovatil standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT temarveldej standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT muftig standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT ogatak standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT orfaoa standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT ossenkoppeleg standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT porwita standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT preijersf standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT richardss standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT schuurhuisg standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT subirad standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes AT valentp standardizationofflowcytometryinmyelodysplasticsyndromesreportfromthefirsteuropeanleukemianetworkingconferenceonflowcytometryinmyelodysplasticsyndromes |